Coverage and compliance towards mass drug administration programme against lymphatic filariasis in Vijayapura (Bijapur) district, Karnataka, India

Authors

  • Praveen Kulkarni Department of Community Medicine, JSS Medical College, Mysuru, Karnataka, India
  • Amoghashree . Department of Community Medicine, JSS Medical College, Mysuru, Karnataka, India
  • Krishnaveni Y. S. Department of Community Medicine, JSS Medical College, Mysuru, Karnataka, India
  • M. R. Narayana Murthy Department of Community Medicine, JSS Medical College, Mysuru, Karnataka, India
  • K. Ravi Kumar Ministry of Health and Family Welfare department, Government of Karnataka, Karnataka, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20183965

Keywords:

Elephantiasis, Lymphatic filariasis, Compliance, Coverage, MDA, Vijayapura district

Abstract

Background: Lymphatic filariasis or elephantiasis is the most debilitating and disfiguring scourge among all diseases. The National Health Policy (2017) has set the goal of elimination of lymphatic filariasis in endemic pockets in India by 2017. The concept of MDA is to approach every individual in the target community and administer annual single dose of anti-filarial drugs. The objectives of the study were to assess the coverage, compliance and causes for noncompliance towards MDA in Vijayapura district and to assess the rates of directly observed treatment, source of information on MDA and incidence of side effects related to MDA Programme.

Methods: This cross-sectional study was conducted in one urban and three rural clusters in Vijayapura district of Karnataka. Totally 120 houses were covered with minimum of 30 houses in each of the cluster. Data was collected in a structured proforma by interview technique and entered in Microsoft Excel-2010 and analyzed with SPSS version 22.

Results: Out of 120 houses visited in 4 clusters consisting of 398 beneficiaries, the coverage of MDA was 80.3% and 72.5% had consumed the tablets. The coverage compliance gap was 7.8%. 71.7% of the respondents, had awareness regarding elephantiasis. The most common reason quoted by the beneficiaries for not consuming the tablet was lack of information of MDA programme/ Lf (13%) followed by fear of drugs (10%).

Conclusions: BCC is the essence of the hour to fulfil the goal of elimination of lymphatic filariasis; there is need for intensive IEC activities addressing the misconceptions among beneficiaries regarding adverse reactions of MDA through mass media, interpersonal communications.

Author Biography

Amoghashree ., Department of Community Medicine, JSS Medical College, Mysuru, Karnataka, India

community medicine

References

Kishore J. J Kishore’s National Health Programmes in India. 7th edition. New Delhi: Century Publications; 2007.

WHO. Lymphatic filariasis. WHO. Available at: http://www.who.int/mediacentre/factsheets/fs102/en/. Accessed on 01 February 2018.

NVBDCP. National Vector Borne Disease Control Programme. Available at: http://www.nvbdcp.gov. in/filariasis.html Accessed on 01 February 2018.

Park K. Park’s Text Book of Preventive and social Medicine.20th edition. Jabalpur: M/s Banarasidas Bhanot; 2009.

Elimination of Lymphatic Filariasis, Training Manual on Mass Drug Administration and Morbidity Management. New Delhi: Ministry of Health and Family Welfare, NVBDCP, Government of India. 2004.

Bhalwar R. Text Book of Public Health and Community Medicine. 1st ed. Department of Community Medicine, AFMC: Pune; 2009.

Government of India. Operational guidelines on elimination of lymphatic Þ lariasis. 2005, Directorate NVBDCP, 22. Shamnath Marg, Delhi 110054

Waseem A, Dorle AS, Mannapur BS, Vetri S. Coverage and compliance of mass drug administration for elimination of lymphatic filariasis in Bijapur District, Karnataka. Ann Community Health. 2014;2:6-10.

Ranganath BG. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India. J Vector Borne Dis. 2010;47:61-4.

Kulkarni P, Kumar R, Rajegowda RM, Channabasappa HG, Ashok NC. MDA Program against lymphatic filariasis: Are we on the path to success? Experience from Uttara Kannada District, Karnataka. Int J Med Public Health. 2014;4:243-6.

Koradhanyamath DM, Kulkarni P, Holla R. Coverage and compliance MDA programme for lymphatic filariasis in Bidar district, Karnataka, India. Asian Pac J Trop Dis. 2012;2(4):290-2.

Kumar A, Kumar P, Nagaraj K, Nayak D, Ashok L, Ashok K. A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India. Vector Borne Dis. 2009;46:237–40.

Kumar P, Prajapati PB, Saxena D, Kavishwar AB, Kurian G. An Evaluation of Coverage and Compliance of Mass Drug Administration 2006 of Elimination of Lymphatic Filariasis in Endemic Areas of Gujarat. Indian J Community Med. 2008;33(1):38-42.

Downloads

Published

2018-09-24

How to Cite

Kulkarni, P., ., A., Y. S., K., Narayana Murthy, M. R., & Ravi Kumar, K. (2018). Coverage and compliance towards mass drug administration programme against lymphatic filariasis in Vijayapura (Bijapur) district, Karnataka, India. International Journal Of Community Medicine And Public Health, 5(10), 4311–4315. https://doi.org/10.18203/2394-6040.ijcmph20183965

Issue

Section

Original Research Articles